NICE guidelines (NG87) recommend methylphenidate, lisdexamfetamine, atomoxetine, or guanfacine as evidence-based ADHD treatments
Congratulations to the authors Amalie Dyrelund Broks, Mads Brner Kristensen, Bolette Hartmann, Knud Josefsen, Jens Juul Holst, and Tue Kragstrup for their work - and for helping chart exciting new research avenues and novel treatment approaches for patients. You can find the paper, Detection of GLP-1 and DPP-4 in synovial fluid: implications for therapeutical strategies in arthriti, here: #GLP1 #Rheumatology #Arthritis #TranslationalResearch #ClinicalResearch #Inflammation Fascinating direction
The story extends beyond biology into behavior, where the impact shows up clearly in the data
No, a doctor referral is not required to enroll in our weight loss program in Lubbock, Texas